BPH (BENIGN PROSTATIC HYPERPLASIA)
Clinical trials for BPH (BENIGN PROSTATIC HYPERPLASIA) explained in plain language.
Never miss a new study
Get alerted when new BPH (BENIGN PROSTATIC HYPERPLASIA) trials appear
Sign up with your email to follow new studies for BPH (BENIGN PROSTATIC HYPERPLASIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for men whose prostate pills Don't work
Disease control Recruiting nowThis study is testing whether adding a second medication (raloxifene) to a standard prostate drug (finasteride) works better for men with an enlarged prostate. It aims to help men whose symptoms don't improve enough with the standard drug alone. Researchers will also check if a s…
Matched conditions: BPH (BENIGN PROSTATIC HYPERPLASIA)
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Mar 24, 2026 12:15 UTC
-
New prostate treatment aims to target symptoms without pills
Disease control Recruiting nowThis study is testing a new treatment called RT-310 for men with bothersome urinary symptoms from an enlarged prostate (BPH). The goal is to see if delivering medication directly to the prostate is safe and practical, aiming to relieve symptoms while minimizing side effects throu…
Matched conditions: BPH (BENIGN PROSTATIC HYPERPLASIA)
Phase: PHASE1, PHASE2 • Sponsor: Resurge Therapeutics Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
New fluid treatment aims to ease Men's nighttime bathroom trips
Symptom relief Recruiting nowThis study is testing whether a treatment called INTUPRO can improve urinary symptoms and quality of life for men with an enlarged prostate (BPH). About 30 men will receive the treatment and then be checked at 1 and 3 months to see if it helps with problems like weak urine flow, …
Matched conditions: BPH (BENIGN PROSTATIC HYPERPLASIA)
Phase: NA • Sponsor: inTumo Therapeutics, Inc. • Aim: Symptom relief
Last updated Mar 23, 2026 15:18 UTC